| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| nccn guidelines cancer associated vte | 1.37 | 1 | 3187 | 47 | 37 |
| nccn | 0.34 | 0.4 | 2211 | 32 | 4 |
| guidelines | 0.64 | 0.2 | 323 | 23 | 10 |
| cancer | 0.92 | 0.6 | 8440 | 86 | 6 |
| associated | 1.36 | 0.4 | 4331 | 59 | 10 |
| vte | 1.51 | 0.1 | 2575 | 83 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| nccn guidelines cancer associated vte | 0.95 | 0.5 | 6161 | 54 |
| cancer associated vte guidelines | 0.14 | 1 | 7275 | 43 |
| cancer associated vte nhs | 1.41 | 0.1 | 1000 | 26 |
| nccn guidelines vte prophylaxis | 0.58 | 0.3 | 4703 | 67 |
| vte in cancer patients | 1.35 | 0.4 | 8191 | 67 |
| clinical practice guidelines vte | 0.36 | 0.5 | 2585 | 47 |
| vte prophylaxis guidelines cancer patients | 1.19 | 0.8 | 3823 | 69 |
| nice guidelines on vte | 1.73 | 0.9 | 5700 | 56 |
| vte in hospital prevention guidelines | 0.99 | 0.9 | 7695 | 16 |
| treatment of vte in cancer patients | 1 | 0.3 | 7228 | 56 |
| nccn guidelines by cancer type | 1.25 | 0.4 | 7295 | 99 |
| vte assessment nice guidelines | 0.56 | 0.7 | 413 | 81 |
| clinical nccn guidelines by cancer type | 1.48 | 0.8 | 6999 | 51 |
| cancer treatment guidelines nccn | 1.43 | 0.6 | 9041 | 34 |
| accp guidelines for vte | 0.9 | 0.9 | 2754 | 58 |
| nice vte prevention guidelines | 1.22 | 0.2 | 950 | 52 |
| vte risk nice guidelines | 1.73 | 0.2 | 2020 | 77 |
| nice guidelines vte treatment | 1.07 | 0.4 | 3218 | 20 |
| green top guidelines vte | 0.69 | 0.8 | 6707 | 79 |
| vte prophylaxis in cancer patients | 1.25 | 0.2 | 8047 | 51 |
| vte nice guidelines 2021 | 1.59 | 0.7 | 8777 | 86 |
| clinical care standard vte | 1.5 | 1 | 2143 | 17 |
| cancer-vte registry | 0.76 | 0.5 | 2430 | 8 |
